Rare diseases
Investigational molecules
Locations
Back to Germany295 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
GermanyStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
GermanyStudy on the Effectiveness and Safety of Dexamfetamine Sulfate for Adults with ADHD
GermanyStudy on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension
GermanyStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
GermanyStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
GermanyStudy on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema
GermanyStudy on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma
GermanyStudy of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
GermanyStudy on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.
Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.
Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.
Evaluating new combination therapies and targeted treatments for improved patient outcomes.
Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.
Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
